Carla Casulo
机构：University of Rochester Medicine, University of Rochester · ORCID：0000-0001-9993-5065
发表论文 44 篇 · 总被引 1001 次 · h-index 14
代表论文
- Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma (2024 · New England Journal of Medicine · 被引 224)
- Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma (2021 · Journal of Clinical Oncology · 被引 57)
- Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 (2025 · Journal of Clinical Oncology · 被引 25)
- International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma (2024 · Journal of Clinical Oncology · 被引 22)
- Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (2025 · Journal of Clinical Oncology · 被引 15)
- Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Final Results from the Phase 2 PRIMO Trial (2024 · Blood · 被引 13)